211 related articles for article (PubMed ID: 20962090)
1. Marek's disease virus type 1 microRNA miR-M3 suppresses cisplatin-induced apoptosis by targeting Smad2 of the transforming growth factor beta signal pathway.
Xu S; Xue C; Li J; Bi Y; Cao Y
J Virol; 2011 Jan; 85(1):276-85. PubMed ID: 20962090
[TBL] [Abstract][Full Text] [Related]
2. Virus-encoded miR-155 ortholog is an important potential regulator but not essential for the development of lymphomas induced by very virulent Marek's disease virus.
Yu ZH; Teng M; Sun AJ; Yu LL; Hu B; Qu LH; Ding K; Cheng XC; Liu JX; Cui ZZ; Zhang GP; Luo J
Virology; 2014 Jan; 448():55-64. PubMed ID: 24314636
[TBL] [Abstract][Full Text] [Related]
3. Virus-encoded miR-155 ortholog in Marek's disease virus promotes cell proliferation via suppressing apoptosis by targeting tumor suppressor WWOX.
Zhu ZJ; Teng M; Li HZ; Zheng LP; Liu JL; Yao Y; Nair V; Zhang GP; Luo J
Vet Microbiol; 2021 Jan; 252():108919. PubMed ID: 33191002
[TBL] [Abstract][Full Text] [Related]
4. Marek's disease virus-encoded analog of microRNA-155 activates the oncogene c-Myc by targeting LTBP1 and suppressing the TGF-β signaling pathway.
Chi JQ; Teng M; Yu ZH; Xu H; Su JW; Zhao P; Xing GX; Liang HD; Deng RG; Qu LH; Zhang GP; Luo J
Virology; 2015 Feb; 476():72-84. PubMed ID: 25528440
[TBL] [Abstract][Full Text] [Related]
5. The significance of the individual Meq-clustered miRNAs of Marek's disease virus in oncogenesis.
Teng M; Yu ZH; Sun AJ; Min YJ; Chi JQ; Zhao P; Su JW; Cui ZZ; Zhang GP; Luo J
J Gen Virol; 2015 Mar; 96(Pt 3):637-649. PubMed ID: 25502647
[TBL] [Abstract][Full Text] [Related]
6. Critical role of the virus-encoded microRNA-155 ortholog in the induction of Marek's disease lymphomas.
Zhao Y; Xu H; Yao Y; Smith LP; Kgosana L; Green J; Petherbridge L; Baigent SJ; Nair V
PLoS Pathog; 2011 Feb; 7(2):e1001305. PubMed ID: 21383974
[TBL] [Abstract][Full Text] [Related]
7. Marek's disease virus encodes MicroRNAs that map to meq and the latency-associated transcript.
Burnside J; Bernberg E; Anderson A; Lu C; Meyers BC; Green PJ; Jain N; Isaacs G; Morgan RW
J Virol; 2006 Sep; 80(17):8778-86. PubMed ID: 16912324
[TBL] [Abstract][Full Text] [Related]
8. Marek's disease virus type 1 encoded analog of miR-155 promotes proliferation of chicken embryo fibroblast and DF-1 cells by targeting hnRNPAB.
Dang L; Teng M; Li HZ; Ma SM; Lu QX; Hao HF; Zhao D; Zhou EM; Zhang GP; Luo J
Vet Microbiol; 2017 Aug; 207():210-218. PubMed ID: 28757026
[TBL] [Abstract][Full Text] [Related]
9. mdv1-miR-M7-5p, located in the newly identified first intron of the latency-associated transcript of Marek's disease virus, targets the immediate-early genes ICP4 and ICP27.
Strassheim S; Stik G; Rasschaert D; Laurent S
J Gen Virol; 2012 Aug; 93(Pt 8):1731-1742. PubMed ID: 22513387
[TBL] [Abstract][Full Text] [Related]
10. Marek's Disease Virus Cluster 3 miRNAs Restrict Virus' Early Cytolytic Replication and Pathogenesis.
Liao Y; Zhuang G; Sun A; Khan OA; Lupiani B; Reddy SM
Viruses; 2020 Nov; 12(11):. PubMed ID: 33212952
[TBL] [Abstract][Full Text] [Related]
11. Virus-encoded microRNA-M7 restricts early cytolytic replication and pathogenesis of Marek's disease virus.
Sun A; Liao Y; Liu Y; Yang S; Wang X; Zhu X; Teng M; Chai S; Luo J; Zhang G; Zhuang G
Vet Microbiol; 2021 Aug; 259():109082. PubMed ID: 34144834
[TBL] [Abstract][Full Text] [Related]
12. Hyperediting by ADAR1 of a new herpesvirus lncRNA during the lytic phase of the oncogenic Marek's disease virus.
Figueroa T; Boumart I; Coupeau D; Rasschaert D
J Gen Virol; 2016 Nov; 97(11):2973-2988. PubMed ID: 27655063
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA profile of Marek's disease virus-transformed T-cell line MSB-1: predominance of virus-encoded microRNAs.
Yao Y; Zhao Y; Xu H; Smith LP; Lawrie CH; Watson M; Nair V
J Virol; 2008 Apr; 82(8):4007-15. PubMed ID: 18256158
[TBL] [Abstract][Full Text] [Related]
14. Differential attenuation of Marek's disease virus-induced tumours and late-Marek's disease virus-induced immunosuppression.
Faiz NM; Cortes AL; Guy JS; Reddy SM; Gimeno IM
J Gen Virol; 2018 Jul; 99(7):927-936. PubMed ID: 29767614
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of Marek's disease virus serotype 1 (MDV1) ICP22 gene product: MDV1 ICP22 transactivates the MDV1 ICP27 promoter synergistically with MDV1 ICP4.
Kato K; Izumiya Y; Tohya Y; Takahashi E; Hirai K; Kawaguchi Y
Vet Microbiol; 2002 Apr; 85(4):305-13. PubMed ID: 11856580
[TBL] [Abstract][Full Text] [Related]
16. Marek's Disease Virus RLORF4 Inhibits Type I Interferon Production by Antagonizing NF-κB Activation.
Liu Y; Gao L; Xu Z; Luo D; Zhang Y; Gao Y; Liu C; Zhang Y; Qi X; Cui H; Li K; Wang X
J Virol; 2019 Sep; 93(18):. PubMed ID: 31243133
[TBL] [Abstract][Full Text] [Related]
17. The interplay between MDV and HVT affects viral miRNa expression.
Goher M; Hicks JA; Liu HC
Avian Dis; 2013 Jun; 57(2 Suppl):372-9. PubMed ID: 23901749
[TBL] [Abstract][Full Text] [Related]
18. Marek's disease herpesvirus transforming protein MEQ: a c-Jun analogue with an alternative life style.
Liu JL; Kung HJ
Virus Genes; 2000; 21(1-2):51-64. PubMed ID: 11022789
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-10a silencing reverses cisplatin resistance in the A549/cisplatin human lung cancer cell line via the transforming growth factor-β/Smad2/STAT3/STAT5 pathway.
Sun W; Ma Y; Chen P; Wang D
Mol Med Rep; 2015 May; 11(5):3854-9. PubMed ID: 25586740
[TBL] [Abstract][Full Text] [Related]
20. Marek's disease: Genetic regulation of gallid herpesvirus 2 infection and latency.
Gennart I; Coupeau D; Pejaković S; Laurent S; Rasschaert D; Muylkens B
Vet J; 2015 Sep; 205(3):339-48. PubMed ID: 26067852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
